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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the effect of singing on health-related quality of life and dyspnoea in people with COPD.
B A C K G R O U N D
Description of the condition
Chronic obstructive pulmonary disease (COPD) is a progressive
lung disease characterised by airflow limitation that is not fully re-
versible and is associated with an abnormal inflammatory response
of the lungs tonoxious particles or gases (GOLD2013). The preva-
lence of COPD has been reported as ranging from 0.2% to 37%,
and varies widely across countries and populations (Rycroft 2012).
Prevalence and incidence is greatest inmen and those aged 75 years
and over (Rycroft 2012). COPD is a major cause of morbidity and
is the third most common cause of death globally (Lozano 2012).
Symptoms of COPD include dyspnoea, cough and fatigue. Re-
duced functional capacity and physical inactivity are common fea-
tures (Troosters 2010; Singer 2011), which significantly increase
the risk for hospitalisation andmortality (Garcia-Aymerich 2006).
Pulmonary rehabilitation is an important component in the man-
agement of COPD and is beneficial in relieving dyspnoea and
fatigue, and improving health-related quality of life and exercise
capacity (McCarthy 2015).
Description of the intervention
Singing is the production of musical words or sounds with the
voice (Oxford 2016). Singing can be performed individually or
in a group (choir), and can be arranged or improvised. Singing is
a much more complex physical activity than speaking due to the
greater length of phrases and greater range of pitch required (Irons
2010). Singing is dependent on the use of the lungs for air sup-
ply. During normal tidal breathing, the diaphragm contracts for
inhalation, while exhalation occurs passively. During singing, air
flow must be regulated and large lung volumes are required, thus
exhalation is active and aided by the abdominal, internal inter-
1Singing for adults with chronic obstructive pulmonary disease (COPD) (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
costal and pelvic muscles. Singing requires a high degree of mus-
cle coordination by highly developed muscle reflexes. There are
four stages of breathing with singing: inhalation, suspension, con-
trolled exhalation (when phonation occurs) and recovery. A singer
controls these stages consciously until they become conditioned
reflexes (Mathis 2009).
Diaphragmatic breathing is the method employed by singers, as
the diaphragm can generate the greatest inspiratory muscle force
to increase lung volumes and change sub-glottal pressures neces-
sary for singing (Sundberg 1993). The sub-glottal air pressure re-
quirements are much greater for singing tasks than for speaking
tasks (Leanderson 1987; Leanderson 1988), as higher sub-glottal
pressures are required for loudness and higher pitch (Sundberg
1993). Audible speech can be produced with sub-glottal pressures
as low as 2 cmH2O with ordinary speech ranging from 7 cmH2O
to 10 cmH2O; however, singing can vary from 5 cmH2O to 40
cmH2O for soft to loud tones (Proctor 1980). An increase in sub-
glottal pressure is achieved by decreasing the volume of the rib
cage using muscular forces, elasticity forces and gravity (Sundberg
1993).
Posture can greatly affect the quantity of air, the capacity of the
lungs and the ability to move air in and out when singing. Good
posture facilitates an efficient breathing pattern and can influence
the voice (Bunch 1995; Staes 2011). Trained singers have greater
breathing efficiency and greater use of their lung capacity than
non-trained singers (Gould 1973; Salomoni 2016).
Mastery of diaphragmatic breathing is vital for singing. Data from
Engen 2005 suggests a minimum of two half-hour sessions could
be sufficient for people with emphysema to learn the diaphrag-
matic breathing technique correctly. Singing needs to be per-
formed at a sufficient intensity and for a sufficient duration in or-
der to ensure an effective stimulus for learning this technique and
for potentially having an effect on important health outcomes.
The precise ’dosage’ will likely vary for each person (Irons 2010).
How the intervention might work
Singing is an activity that has the potential to improve health out-
comes, such as relieving dyspnoea and enhancing quality of life,
in people with COPD. Qualitative studies of singing and health
report that singing can enhance mood, provide social support and
friendship, help develop self esteem and self confidence, relieve
stress, promote good posture and distract attention from personal
worries (MacDonald 2012). Singing in people with COPD has
the potential to demonstrate similar effects due to the enjoyable
and low-risk nature of the activity (Engen 2005), and may have a
positive impact on the distressing effects of COPD such as breath-
lessness, reduced quality of life and fatigue. The perceptions of
people with COPD following a group singing programme support
this (Morrison 2013; Skingley 2014).
Therapies that incorporate breathing manoeuvres, such as con-
trolled breathing techniques including active expiration (as per-
formed during singing), have been shown to improve lung func-
tion (Esteve 1996), alleviate dyspnoea and improve quality of life
(Gosselink 2003; Gosselink 2004), and improve functional exer-
cise capacity (Holland 2012) in people with COPD. Singing re-
quires great control to ensure a smooth and sustained exhalation.
This exhalation is similar to that of pursed lip breathing and con-
trolled breathing that have been shown to reduce breathlessness in
people with COPD (Gosselink 2003; Bianchi 2004).
Education on breathing and air support is fundamental in learning
to sing, and knowledge of the physical processes that make up the
act of singing and how those processes function (Mathis 2009)
may improve breathing awareness and efficiency in people with
COPD.
Poor posture (hyperkyphosis), which is common in people with
COPD, can restrict the expansion of the rib cage and movement
of the diaphragm. Singing requires the development of skills in
controlling posture that may be transferable to activities in daily
life in people with COPD (Lord 2010).
Why it is important to do this review
Singing may have the potential to improve health outcomes in
people with COPD. Systematic reviews of research literature have
been completed for singing in other chronic respiratory diseases
such as bronchiectasis (Irons 2010), and cystic fibrosis (Irons
2014), and found an absence of randomised controlled trials
(RCTs) to support or refute the benefits of singing. However, the
authors of these reviews found studies that reported an improve-
ment in quality of life in people with COPD, and a systematic
review of singing for COPD has not yet been carried out.
O B J E C T I V E S
To determine the effect of singing on health-related quality of life
and dyspnoea in people with COPD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include RCTs reported as full-text, published as abstract
only and unpublished data. We will use data from studies pub-
lished as abstract onlywhere authors canprovide study data.Where
the data are not available, we will record the studies as awaiting
classification.
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Types of participants
Wewill include studies that involve adults with COPD, diagnosed
according to the investigators’ definition, of any age or disease
severity. TheCOPD should be stable (i.e. optimal and stable respi-
ratory medications with no exacerbation or hospitalisation within
the previous month). We will allow participants using supplemen-
tal oxygen. We will include participants with and without a his-
tory of singing training, and record the singing training history
wherever possible.
Types of interventions
We will include studies examining structured supervised singing
training of at least four weeks’ duration with a minimum of four
sessions. Studies will be included that compare:
1. singing versus no intervention (usual care) or a control
group;
2. singing plus pulmonary rehabilitation versus pulmonary
rehabilitation alone.
The singing may be performed individually or as part of a group
(choir) facilitated by a singing teacher or instructor, and will in-
clude inpatient and outpatient programmes. We will record the
precise nature of the singing facilitators’ professional backgrounds,
singing training and any pulmonary rehabilitation programme
(frequency, duration, type, intensity) wherever possible.
Types of outcome measures
Primary outcomes
1. Health-related quality of life measured using total scores
from either generic or respiratory-specific quality-of-life
questionnaires.
2. Dyspnoea measured using a dyspnoea scale (e.g. Medical
Research Council (MRC) dyspnoea scale) or dyspnoea scores
from a respiratory-specific quality-of-life questionnaire (e.g.
dyspnoea from the Chronic Respiratory Disease Questionnaire),
or both.
Secondary outcomes
1. Respiratory muscle strength measured from a pressure
gauge (e.g. maximal inspiratory and expiratory mouth pressures
or maximal sniff nasal inspiratory pressure).
2. Pulmonary function measured by spirometry or
plethysmography (e.g. forced expiratory volume in one second
(FEV1) measured in litres or as per cent of predicted, forced vital
capacity (FVC), FEV1/FVC, total lung capacity (TLC), residual
capacity (RC), functional residual capacity (FRC)).
3. Psychological status measured from generic psychological
questionnaires or scales (e.g. Hospital Anxiety and Depression
Scale).
4. Functional exercise capacity measured from a functional
exercise test.
5. Peak exercise capacity measured from a peak exercise test.
6. Endurance exercise capacity measured from an endurance
exercise test.
7. Healthcare utilisation recorded as hospitalisation or length
of hospital stay, or both.
8. Physical activity level from objective measurement tools
(e.g. pedometers, accelerometers, multi-sensor devices).
9. Adverse events/side effects.
Reporting one ormore of the outcomes listed here in the study will
not be an inclusion criterion for the review. Primary and secondary
outcomes will be reviewed at baseline and immediately following
the intervention period. If outcomes are alsomeasured in the long-
term (e.g. six or 12 months after completion of intervention), this
will also be reviewed at each time point in addition to immediately
following the intervention period. The selected primary outcome
measures are important to patients and clinicians, and all outcome
measures are clinically relevant and may potentially be altered by
a singing intervention.
Search methods for identification of studies
Electronic searches
We will identify trials from the Cochrane Airways Group’s Spe-
cialised Register (CAGR), which is maintained by the Informa-
tion Specialist for the Group. The Register contains trial reports
identified through systematic searches of bibliographic databases
including the Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, EMBASE, CINAHL, AMED and
PsycINFO, and handsearching of respiratory journals and meet-
ing abstracts (see Appendix 1 for further details). We will search
all records in the CAGR using the search strategy in Appendix 2.
We will also conduct a search of ClinicalTrials.gov (
www.ClinicalTrials.gov) and the World Health Organization
(WHO) trials portal (www.who.int/ictrp/en/) and PEDro (
www.pedro.org.au/).We will search all databases from their incep-
tion to the present, and we will impose no restriction on language
of publication.
Searching other resources
We will check reference lists of all primary studies and review ar-
ticles for additional references. We will search for errata or retrac-
tions from included studies published in full-text on PubMed (
www.ncbi.nlm.nih.gov/pubmed) and report the date thiswas done
within the review.
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Data collection and analysis
Selection of studies
Two review authors (RJM, CE) will independently screen titles
and abstracts for inclusion of all the potential studies we identify
as a result of the search and code them as ’retrieve’ (eligible or po-
tentially eligible/unclear) or ’do not retrieve’. We will retrieve the
full text study reports/publication and two review authors (RJM,
CE) will independently screen the full text and identify studies for
inclusion, and identify and record reasons for exclusion of the in-
eligible studies. We will resolve any disagreement through discus-
sion or, if required, we will consult a third review author (ZJM).
We will identify and exclude duplicates and collate multiple re-
ports of the same study so that each study rather than each report
is the unit of interest in the review. We will record the selection
process in sufficient detail to complete a PRISMA flow diagram
and ’Characteristics of excluded studies’ table (Moher 2009).
Data extraction and management
We will use a data collection form for study characteristics and
outcome data that has been piloted on at least one study in the
review. One review author (RJM) will extract study characteristics
from included studies. We will extract the following study char-
acteristics:
1. methods: study design, total duration of study, details of
any ’run-in’ period, number of study centres and location, study
setting, withdrawals and date of study;
2. participants: number, mean age, age range, gender, severity
of condition, diagnostic criteria, baseline lung function, smoking
history, inclusion criteria and exclusion criteria;
3. interventions: intervention, comparison, concomitant
medications and excluded medications;
4. outcomes: primary and secondary outcomes specified and
collected, and time points reported;
5. notes: funding for trial and notable conflicts of interest of
trial authors.
Two review authors (RJM, CE) will independently extract out-
come data from included studies. We will note in the ’Character-
istics of included studies’ table if outcome data were not reported
in a usable way. We will resolve disagreements by consensus or by
involving a third review author (ZJM). One review author (RJM)
will transfer data into Review Manager 5 (RevMan 2014). We
will double-check that data are entered correctly by comparing the
data presented in the systematic review with the study reports. A
second review author (EC) will spot-check study characteristics
for accuracy against the trial report.
Assessment of risk of bias in included studies
Two review authors (RJM, CE) will independently assess risk of
bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We will resolve any disagreements by discussion or by involving
another review author (ZJM). We will assess the risk of bias ac-
cording to the following domains:
1. random sequence generation;
2. allocation concealment;
3. blinding of participants and personnel;
4. blinding of outcome assessment;
5. incomplete outcome data;
6. selective outcome reporting;
7. other bias.
We will grade each potential source of bias as high, low or un-
clear and provide a quote from the study report together with a
justification for our judgement in the ’Risk of bias’ table. We will
summarise the ’Risk of bias’ judgements across different studies for
each of the domains listed. We will consider blinding separately
for different key outcomes where necessary (e.g. for unblinded
outcome assessment). Where information on risk of bias relates to
unpublished data or correspondence with a trialist, we will note
this in the ’Risk of bias’ table.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
Assessment of bias in conducting the systematic
review
We will conduct the review according to this published protocol
and report any deviations from it in the ’Differences between pro-
tocol and review’ section of the systematic review.
Measures of treatment effect
We will analyse dichotomous data as odds ratios (OR) and con-
tinuous data as mean difference (MD) or standardised mean dif-
ference (SMD). We will enter data presented as a scale with a con-
sistent direction of effect.
We will undertake meta-analyses only where this is meaningful,
that is, if the treatments, participants and the underlying clinical
question are similar enough for pooling to make sense.
Wewill describe skewed data reported asmedians and interquartile
ranges narratively.
Where multiple trial arms are reported in a single trial, we will
include only the relevant arms. If two comparisons are combined
in the samemeta-analysis, we will halve the control group to avoid
double-counting.
Unit of analysis issues
We will not include cross-over trials. If the search identifies clus-
ter randomised trials, we will consult the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011).
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Dealing with missing data
We will contact investigators or study sponsors in order to verify
key study characteristics and obtain missing numerical outcome
data where possible (e.g. when a study is identified as abstract
only). Where this is not possible, and the missing data are thought
to introduce serious bias, we will explore the impact of including
such studies in the overall assessment of results by conducting a
sensitivity analysis.
Assessment of heterogeneity
We will use the I2 statistic to measure heterogeneity among the
studies in each analysis. If we identify substantial heterogeneity, we
will report it and explore possible causes by prespecified subgroup
analysis.
Assessment of reporting biases
If we are able to pool more than 10 studies, we will create and
examine a funnel plot to explore possible small-study and publi-
cation biases.
Data synthesis
Wewill use a random-effects model and perform a sensitivity anal-
ysis with a fixed-effect model using Review Manager 5 (RevMan
2014). If the outcomes are reported using adjusted analyses (such
as ANOVA or ANCOVA), we will use the generic inverse variance
method to combine the results with other studies; if adjusted anal-
yses are not available, we will prefer change from baseline results
to final scores.
’Summary of findings’ table
We will create a ’Summary of findings’ table using the following
outcomes: health-related quality of life, dyspnoea, respiratorymus-
cle strength and adverse events. We will use the five GRADE con-
siderations (study limitations, consistency of effect, imprecision,
indirectness and publication bias) to assess the quality of a body
of evidence as it relates to the studies that contribute data to the
meta-analyses for the prespecified outcomes. We will use methods
and recommendations described in Section 8.5 and Chapter 12
of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011) using GRADEpro software (GRADEpro GDT).
We will justify all decisions to down- or upgrade the quality of
studies using footnotes and we will make comments to aid the
reader’s understanding of the review where necessary.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses if sufficient
studies are retrieved:
1. severity of lung disease - severe (FEV1 % predicted less than
40%) versus not severe (FEV1 % predicted 40% predicted or
greater).
2. mode of singing intervention - individual versus group
(choir);
3. participant’s experience with singing training - no previous
history with singing training versus prior history of singing
training;
4. singing facilitator’s professional background - formally
trained music or singing professional versus health or lay
professional.
We will use the following outcomes in subgroup analyses:
1. health-related quality of life;
2. dyspnoea.
We will use the formal test for subgroup interactions in Review
Manager 5 (RevMan 2014).
Sensitivity analysis
We plan to carry out the following sensitivity analysis:
1. Studies with a low risk of bias (to examine the effects of
removing studies with a high risk of bias).
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A P P E N D I C E S
Appendix 1. Sources and search methods for the Cochrane Airways Group Specialised Register
(CAGR)
Electronic searches: core databases
Database Frequency of search
CENTRAL (the Cochrane Library) Monthly
MEDLINE (Ovid) Weekly
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(Continued)
Embase (Ovid) Weekly
PsycINFO (Ovid) Monthly
CINAHL (EBSCO) Monthly
AMED (EBSCO) Monthly
Handsearches: core respiratory conference abstracts
Conference Years searched
AmericanAcademyofAllergy, Asthma and Immunology (AAAAI) 2001 onwards
American Thoracic Society (ATS) 2001 onwards
Asia Pacific Society of Respirology (APSR) 2004 onwards
British Thoracic Society Winter Meeting (BTS) 2000 onwards
Chest Meeting 2003 onwards
European Respiratory Society (ERS) 1992, 1994, 2000 onwards
International PrimaryCareRespiratoryGroupCongress (IPCRG) 2002 onwards
Thoracic Society of Australia and New Zealand (TSANZ) 1999 onwards
MEDLINE search strategy used to identify trials for the CAGR
COPD search
1. Lung Diseases, Obstructive/
2. exp Pulmonary Disease, Chronic Obstructive/
3. emphysema$.mp.
4. (chronic$ adj3 bronchiti$).mp.
5. (obstruct$ adj3 (pulmonary or lung$ or airway$ or airflow$ or bronch$ or respirat$)).mp.
6. COPD.mp.
7. COAD.mp.
8. COBD.mp.
9. AECB.mp.
10. or/1-9
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Filter to identify RCTs
1. exp “clinical trial [publication type]”/
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
We will adapt the MEDLINE strategy and RCT filter to identify trials in other electronic databases.
Appendix 2. Search strategy to identify relevant trials from the CAGR
#1 MeSH DESCRIPTOR Pulmonary Disease, Chronic Obstructive Explode All
#2 MeSH DESCRIPTOR Bronchitis, Chronic
#3 (obstruct*) near3 (pulmonary or lung* or airway* or airflow* or bronch* or respirat*)
#4 COPD:MISC1
#5 (COPD OR COAD OR COBD OR AECOPD):TI,AB,KW
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 (sing or singing or singer* or song*):ti,ab,kw
#8 (voice* or vocal*) NEAR (exercis* or train*)
#9 diaphragm* NEAR2 breath*
#10 MeSH DESCRIPTOR Music Therapy
#11 choir*:ti,ab,kw
#12 #7 or #8 or #9 or #10 or #11
#13 #6 AND #12
[in search line #4, MISC1 denotes the field in the record where the reference has been coded for condition, in this case, COPD]
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